Características de los fármacos antivirales

Tuset, Montse; Martín-Conde, M. Teresa; Miró, José; Cacho, Elena del; Alberdi, Aintzane; Codina, Carles; Ribas, Josep.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 21(8): 433-458, oct. 2003.
Artículo en Es | IBECS (España) | ID: ibc-25005

Documentos relacionados

  1. Features of Interferon Status and Methods of Its Correction in the Treatment of Patients with Atypical Chronic Active Herpesvirus Infections.
  2. Risk factors for early viral infections after liver transplantation.
  3. Intra vitam assays for detecting fish infected with cyprinid herpesvirus 3 (CyHV-3).
  4. FIRST DETECTION OF CLINICAL DISEASE DUE TO ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS 7A IN TWO AFRICAN ELEPHANTS (<i>LOXODONTA AFRICANA</i>) IN HUMAN CARE.
  5. Revisiting Cryptocyanine Dye, NK-4, as an Old and New Drug: Review and Future Perspectives.
  6. BIOLOGICAL VARIATION OF HEMATOLOGY PARAMETERS AND CLINICAL APPLICATION IN AFRICAN ELEPHANTS (<i>LOXODONTA AFRICANA</i>).
  7. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse.
  8. Intraoral human herpes viruses detectable by PCR in majority of patients.
  9. THE EFFECTIVENESS OF THERAPY BY CRYOPRESERVED HUMAN PLASMA IN PATIENTS WITH DEFICIENCY OF MANNOSE BINDING LECTIN SUFFERING FROM HERPES VIRUS INFECTION.
  10. Characterization of a Unique Novel LORF3 Protein of Duck Plague Virus and Its Potential Pathogenesis.